Company intelligence / Profile preview
Precision BioSciences, Inc.
Durham, North Carolina, United Statesinvestor.precisionbiosciences.com ↗
- Ownership
- Public · DTIL
- Employees
- ~192
- Development stage
- Phase 1
01
Overview
Precision BioSciences has demonstrated early proof-of-concept for its off-the-shelf allogeneic CAR-T therapies with phase I/II data showing potential benefit even in heavily pretreated patients. Its current focus has shifted to advancing its proprietary ARCUS-based in vivo gene editing pipeline, with the lead HBV program progressing through phase I trials. The company continues to expand partnerships and business development opportunities while reporting sufficient financial runway into mid-next year.
- Therapeutic areas
- GastroenterologyOncologyRare DiseasesInfectious Diseases
- Modalities
- Gene editing (in vivo and ex vivo)Allogeneic CAR T-cell therapyGenome editing nucleases (ARCUS platform)
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly & Co.Tiziana Life SciencesiECUREImugene
04
Financials
- Market cap
- $93M
- Total revenue
- $0
- Enterprise value
- $33.6M
Beyond the preview
Go deeper on Precision BioSciences, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precision BioSciences, Inc..